Profil
Esben Nørgaard Flindt was the founder of Unest A, founded in 2003, where he held the title of Chief Scientific Officer, and Ubeamion ApS, founded in 2001, where he held the title of Chief Executive Officer from 2009 to 2012.
Currently, he is the Chief Executive Officer & Director at BioLigands ApS since 2005.
Dr. Flindt's former job was as a Manager at Genetic Signatures Ltd. from 2004 to 2005.
He received his doctorate degree from the University of Southern Denmark in 2004.
Postes actifs de Esben Nørgaard Flindt
| Sociétés | Poste | Début |
|---|---|---|
BioLigands ApS
BioLigands ApS BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur Général | 22/10/2009 |
Anciens postes connus de Esben Nørgaard Flindt
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIC SIGNATURES LIMITED | Corporate Officer/Principal | 01/01/2005 |
Unest A/S
Unest A/S Medical/Nursing ServicesHealth Services Researches in the biotechnology industry | Fondateur | - |
Ubeamion ApS | Fondateur | - |
Formation de Esben Nørgaard Flindt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genetic Signatures Ltd.
Genetic Signatures Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes diagnostic kits | Commercial Services |
Unest A/S
Unest A/S Medical/Nursing ServicesHealth Services Researches in the biotechnology industry | Health Services |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLigands ApS
BioLigands ApS BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Ubeamion ApS |
















